Skip to main content
. 2009 Oct 9;75(23):7488–7500. doi: 10.1128/AEM.01829-09

TABLE 1.

F. tularensis strains used in this study

Strain Designation Subtype Region Origin Year isolated
F. tularensis subsp. holarctica LVS LVSb B Europe Sheep 1949
F. tularensis subsp. novicida U112 NOV NA Utah Human 1951
F. tularensis subsp. tularensis strains
    Schu S4 SCHUc A Ohio Human lesion 1941
    70102163 Ft-1 Aa Utah Human blood 2001
    79101574 Ft-2 Aa Utah Human 1991
    1365 Ft-3 Aa New Mexico Human 1997
    AS1284 Ft-4 Aa New Mexico Rodent 2003
    79400960 Ft-5 Aa Utah Human 1990
    80700069 Ft-6 Aa Utah Human lesion 2007
    80502541 Ft-7 Aa Utah Human lesion 2005
    1385 Ft-8 Aa New Mexico Rabbit 2001
    1773a Ft-9 Aa New Mexico Human 1999
    AS2058 Ft-10 Aa New Mexico Rabbit 2002
a

Subtyping was done using primers in IS100 elements unique to type A strains (Victoria Lao, Patrick Chain, and Emilio Garcia, unpublished results).

b

LVS was produced as a vaccine in 1961 by passaging a virulent F. tularensis subsp. holarctica strain isolated in 1949 (17).

c

Laboratory-passaged strain.